Tripeptide has demonstrated significant glucose-lowering and weight-reducing effects, not only in clinical trials but also in Japanese real-world settings [8,9,10,11,12]
The goal is to work with your body's natural systems, not against them, and that requires a professional, personalized approach
Our gastroenterology specialists at Cleveland Clinic can help.
AOD-9604 is a fat-targeting peptide that specifically targets lipolysis, or fat breakdown, without influencing glucose metabolism
Researchers continue to explore how this controlled stimulation may influence: Tissue repair processes Cellular regeneration Recovery pathways Muscle protein synthesis Metabolic efficiency Growth factor production The growing body of scientific literature surrounding growth hormone secretagogues highlights the importance of understanding these mechanisms in greater detail